Broadwood Partners, L.P., Director, 10% Owner at BIOTIME INC (BTX), bought 150,000 shares at $2.80 ($420K) on 2017-07-31, disclosed to the SEC on 2017-08-02.
Open-market purchase of $420k BTX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| STAA | BUY | 2026-03-13 | $12.3M | — | Filing → |
| STAA | BUY | 2026-01-08 | $8.8M | — | Filing → |
| STAA | BUY | 2025-04-07 | $27.2M | — | Filing → |